FDA 执法报告 D-0045-2027:Ascend Laboratories 氨氯地平/奥美沙坦酯片因溶出度不合格被列为 II 类召回
FDA drug enforcement D-0045-2027: Ascend Laboratories, LLC — Out of specification due to dissolution.
FDA 执法报告 D-0045-2027 将 Ascend Laboratories, LLC 的氨氯地平/奥美沙坦酯片(10mg/40mg)召回列为 II 类,原因为溶出度不符合标准。
该条目为 openFDA 执法报告记录,显示氨氯地平/奥美沙坦酯片因溶出度不符合标准被列为 II 类召回,可核对批次与分销范围。
FDA 药品召回执行报告 — D-0045-2027
报告发布日期:2026-10-28。这是执行报告的日期,不是召回启动日期。
范围:一条已分类的药品召回记录;event_id 可能对应多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法结论。
openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所对应的含义。
完整官方产品记录(包括 openFDA 统一标识符):
{
"address_1": "135 Us Highway 202 206 Ste 15",
"address_2": "",
"center_classification_date": "20261016",
"city": "Bedminster",
"classification": "Class II",
"code_info": "批号 25120696,有效期:2026年12月31日。",
"country": "United States",
"distribution_pattern": "美国全国范围",
"event_id": "100053",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {
"application_number": [
"ANDA209042"
],
"brand_name": [
"AMLODIPINE AND OLMESARTAN MEDOXOMIL"
],
"generic_name": [
"AMLODIPINE AND OLMESARTAN MEDOXOMIL"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Ascend Laboratories, LLC"
],
"package_ndc": [
"67877-499-30",
"67877-499-90",
"67877-500-30",
"67877-500-90",
"67877-501-30",
"67877-501-90",
"67877-502-30",
"67877-502-90"
],
"product_ndc": [
"67877-499",
"67877-500",
"67877-501",
"67877-502"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"ORAL"
],
"rxcui": [
"730861",
"730866",
"730869",
"730872"
],
"spl_id": [
"32238052-6c4c-4b29-a59e-524c819c69f1"
],
"spl_set_id": [
"c1204fbe-d086-43cf-bbaa-efec9cd0487c"
],
"substance_name": [
"AMLODIPINE BESYLATE",
"OLMESARTAN MEDOXOMIL"
],
"unii": [
"6M97XTV3HD",
"864V2Q084H"
]
},
"postal_code": "07921-2608",
"product_description": "苯磺酸氨氯地平与奥美沙坦酯片,10mg/40mg,30片装,处方药,生产商:Alkem Laboratories Ltd.,印度,经销商:Ascend Laboratories, LLC,Parsippany, NJ 07054,NDC 67877-502-30。",
"product_quantity": "11,424 瓶。",
"product_type": "Drugs",
"reason_for_recall": "溶出度不符合标准。",
"recall_initiation_date": "20261006",
"recall_number": "D-0045-2027",
"recalling_firm": "Ascend Laboratories, LLC",
"report_date": "20261028",
"state": "NJ",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov